Literature DB >> 25755784

Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.

Qiu-Wei Yin1, Xue-Fei Sun1, Guo-Tao Yang1, Xi-Bo Li1, Ming-Sheng Wu1, Jian Zhao1.   

Abstract

OBJECTIVES: The aim was to evaluate the clinical significance and prognostic value of tissue miR-150 expression in non-small cell lung cancer (NSCLC) patients.
MATERIALS AND METHODS: Quantitative real-time PCR was used to analyze the expression of miR-150. Overall survival (OS) was estimated using the Kaplan-Meier method, and the differences in survival were compared using the log-rank test. A Cox proportional hazards model was used for multivariate analysis.
RESULTS: Mean miR-150 levels were significantly higher in NSCLC tissues compared with matched non-cancerous tissues (4.07 ± 2.33 vs. 1.00 ± 0.46, P < 0.0001). The level of miR-150 in NSCLC was strongly correlated with lymph node metastasis (P = 0.04), distant metastasis (P = 0.01) and clinical TNM stage (P = 0.02). Kaplan-Meier analysis showed that the cumulative 5-year OS rate was 40.8% in the high expression group, and 69.2% in the low expression group. The log-rank test showed that the OS rate of patients with high miR-150 expression was significantly poorer than that of the remaining cases (P = 0.007).
CONCLUSION: Our data indicated that overexpression of miR-150 in NSCLC tissues has prognostic value.

Entities:  

Keywords:  RT-PCR; biomarker; miR-150; microRNA; non-small-cell lung cancer; prognosis

Mesh:

Substances:

Year:  2015        PMID: 25755784      PMCID: PMC4348842     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

1.  microRNA expression profile in undifferentiated gastric cancer.

Authors:  Takeyasu Katada; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitui; Yoichiro Mori; Ryo Ogawa; Koshiro Harata; Yoshitaka Fujii
Journal:  Int J Oncol       Date:  2009-02       Impact factor: 5.650

2.  Meta-analysis of microRNA expression in lung cancer.

Authors:  Urmo Võsa; Tõnu Vooder; Raivo Kolde; Jaak Vilo; Andres Metspalu; Tarmo Annilo
Journal:  Int J Cancer       Date:  2012-12-27       Impact factor: 7.396

Review 3.  MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.

Authors:  Richard Hummel; Damian J Hussey; Joerg Haier
Journal:  Eur J Cancer       Date:  2009-11-28       Impact factor: 9.162

4.  Widespread microRNA repression by Myc contributes to tumorigenesis.

Authors:  Tsung-Cheng Chang; Duonan Yu; Yun-Sil Lee; Erik A Wentzel; Dan E Arking; Kristin M West; Chi V Dang; Andrei Thomas-Tikhonenko; Joshua T Mendell
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

5.  MicroRNAs differentially expressed in ACTH-secreting pituitary tumors.

Authors:  Fernando Colbari Amaral; Natalia Torres; Fabiano Saggioro; Luciano Neder; Hélio Rubens Machado; Wilson Araújo Silva; Ayrton Custódio Moreira; Margaret Castro
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

6.  Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia.

Authors:  Amal A Abd-El-Fattah; Nermin Abdel Hamid Sadik; Olfat Gamil Shaker; Mariam Lotfy Aboulftouh
Journal:  Cell Biochem Biophys       Date:  2013       Impact factor: 2.194

7.  Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro.

Authors:  Xiao-yan Gu; Jun Wang; Yi-zhou Luo; Qiang Du; Ruo-ran Li; Hui Shi; Tian-pei Yu
Journal:  Tumour Biol       Date:  2014-02-16

8.  The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.

Authors:  Mayuko Furuta; Ken-ichi Kozaki; Kousuke Tanimoto; Shinji Tanaka; Shigeki Arii; Teppei Shimamura; Atsushi Niida; Satoru Miyano; Johji Inazawa
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

9.  DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.

Authors:  Zheng Li; Huizi Lei; Min Luo; Yi Wang; Lei Dong; Yanni Ma; Changzheng Liu; Wei Song; Fang Wang; Junwu Zhang; Jianxiong Shen; Jia Yu
Journal:  Gastric Cancer       Date:  2014-01-31       Impact factor: 7.701

10.  MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration.

Authors:  Xin Yu; Zheng Li; Jianxiong Shen; William K K Wu; Jinqian Liang; Xisheng Weng; Guixing Qiu
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more
  12 in total

1.  MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma.

Authors:  Jin Xu; Zengliang Wang; Zhichao Liao; Dong Dai; Xinlong Ma
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

2.  Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150.

Authors:  Duo Zhang; Heedoo Lee; Jeffrey A Haspel; Yang Jin
Journal:  FASEB J       Date:  2017-06-27       Impact factor: 5.191

3.  CASC1 Expression in Bladder Cancer Is Regulated by Exosomal miRNA-150: A Comprehensive Pan-Cancer and Bioinformatics Study.

Authors:  Huarong Luo; Chengdang Xu; Bujun Ge; Tianru Wang
Journal:  Comput Math Methods Med       Date:  2022-07-05       Impact factor: 2.809

Review 4.  Epigenetics in non-small cell lung cancer: from basics to therapeutics.

Authors:  Junaid Ansari; Rodney E Shackelford; Hazem El-Osta
Journal:  Transl Lung Cancer Res       Date:  2016-04

5.  MicroRNA-150 regulates glycolysis by targeting von Hippel-Lindau in glioma cells.

Authors:  Shi-Jie Li; Hong-Lin Liu; Shi-Lei Tang; Xiao-Juan Li; Xiao-Yin Wang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

6.  Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals.

Authors:  Ivan A Zaporozhchenko; Evgeny S Morozkin; Anastasia A Ponomaryova; Elena Y Rykova; Nadezhda V Cherdyntseva; Aleksandr A Zheravin; Oksana A Pashkovskaya; Evgeny A Pokushalov; Valentin V Vlassov; Pavel P Laktionov
Journal:  Sci Rep       Date:  2018-04-20       Impact factor: 4.379

7.  C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.

Authors:  Hui Li; Juan Liu; Wenjie Cao; Xiaojuan Xiao; Long Liang; Feng Liu-Smith; Weiwei Wang; Hong Liu; Peng Zhou; Ruoyun Ouyang; Zhijun Yuan; Jing Liu; Mao Ye; Bin Zhang
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

8.  microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Fujun Yu; Zhongqiu Lu; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  Diagn Pathol       Date:  2015-07-28       Impact factor: 2.644

9.  A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.

Authors:  F Du; P Yuan; Z T Zhao; Z Yang; T Wang; J D Zhao; Y Luo; F Ma; J Y Wang; Y Fan; R G Cai; P Zhang; Q Li; Y M Song; B H Xu
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

10.  miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma.

Authors:  Xinyuan Wang; Yutian Kan; Leiyuan Chen; Peng Ge; Tingting Ding; Qiongli Zhai; Yong Yu; Xiaofang Wang; Zhigang Zhao; Hongliang Yang; Xianming Liu; Lanfang Li; Lihua Qiu; Zhengzi Qian; Huilai Zhang; Yafei Wang; Haifeng Zhao
Journal:  Oncol Lett       Date:  2020-03-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.